DESMOPRESSIN ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Desmopressin Acetate, and what generic alternatives are available?
Desmopressin Acetate is a drug marketed by Am Regent, Bedford, Dr Reddys, Gland, Gland Pharma Ltd, Hospira, Meitheal, Sagent Pharms Inc, Sun Pharm Inds Ltd, UBI, Sun Pharm Inds, Bausch, Abhai Llc, Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma, Ferring, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Natco Pharma Usa, Novast Labs, Apotex, Sun Pharm, and Zydus Pharms. and is included in twenty-eight NDAs.
The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desmopressin Acetate
A generic version of DESMOPRESSIN ACETATE was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.
Summary for DESMOPRESSIN ACETATE
US Patents: | 0 |
Applicants: | 25 |
NDAs: | 28 |
Finished Product Suppliers / Packagers: | 24 |
Raw Ingredient (Bulk) Api Vendors: | 133 |
Clinical Trials: | 10 |
Patent Applications: | 766 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DESMOPRESSIN ACETATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DESMOPRESSIN ACETATE |
What excipients (inactive ingredients) are in DESMOPRESSIN ACETATE? | DESMOPRESSIN ACETATE excipients list |
DailyMed Link: | DESMOPRESSIN ACETATE at DailyMed |
Recent Clinical Trials for DESMOPRESSIN ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | N/A |
Genentech, Inc. | Phase 4 |
Indiana Hemophilia &Thrombosis Center, Inc. | Phase 4 |
Pharmacology for DESMOPRESSIN ACETATE
Drug Class | Factor VIII Activator Vasopressin Analog |
Physiological Effect | Increased Coagulation Factor VIII Activity Increased Coagulation Factor VIII Concentration |
Anatomical Therapeutic Chemical (ATC) Classes for DESMOPRESSIN ACETATE
US Patents and Regulatory Information for DESMOPRESSIN ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco Pharma Usa | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 200653-002 | Jun 27, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Heritage Pharma | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 207880-002 | May 26, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Novast Labs | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 208357-001 | Jun 6, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Impax Labs Inc | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 077122-001 | Jan 25, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DESMOPRESSIN ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferring | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 021795-001 | May 8, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Ferring | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 021795-002 | May 8, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DESMOPRESSIN ACETATE
See the table below for patents covering DESMOPRESSIN ACETATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 1500390 | ⤷ Try a Trial | |
Norway | 327328 | ⤷ Try a Trial | |
New Zealand | 544104 | Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof | ⤷ Try a Trial |
Russian Federation | 2005141230 | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЕСМОПРЕССИНА В ВИДЕ ТВЕРДОЙ ДОЗИРОВАННОЙ ЛЕКАРСТВЕННОЙ ФОРМЫ И СПОСОБ ЕЕ ИЗГОТОВЛЕНИЯ | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DESMOPRESSIN ACETATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3225249 | 2019C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
2712622 | 122017000006 | Germany | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504 |
3225249 | 300983 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513 |
2712622 | C02712622/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |